Type 1 Diabetes Flashcards
Type 1
A state of absolute insulin deficiency
mediated by an auto-immune process of varying degree of severity occurring within pancreatic beta cell
Aetiology
Idiopathic
Twin studies: monozygotic concordance rate 455
Strong association with HLA
- HLA-DR3
- HLA-DR4
Peak age of onset approx 12 years
Clinical presentation at all ages
Pathology
Autoimmune destruction of the beta-cells in the islets of langerhans in the pancreas leading to absolute insulin deficiency
note: Small amounts of insulin can be released up to 5 years after diagnosis
Autoimmune Process
Autoantibodies
- GAD 65
- IAA and IA2
- Znt8
Clinical Presentation
Acute onset
polyuria Polydipsia Weight loss \+/- ketoacidossi Thrush Weakness/fatigue Blurred vision
Ketonuria +/- metabolic acidosis
No evidence of microvascular disease at diagnosis
Diagnosis
Symptomatic; Random Glucose >11/1 mmol/L
Asymptomatic : Oral glucose tolerance test
- Fasting Glucose: >7mmol/l
- 2hr post-glucose load: >11.1mmol/l
history & Presentation
GAD/IA2 antibodies
Absence of C-peptides (<0.2 mmol/l)
Aims of therapy
Prevent hyperglycaemia
Avoid hypoglycaemia
Reduce chronic complications
management of T1DM
Blood glucose and ketone monitoring
Insulin
- basal (once daily) and bolus (with meals) regime
Carbohydrate estimation
Self management education
- DAFNE
- Sick day rules
Regular check of prevailing glycemic control
-HbA1c ideal range: 48mmol/L
Continuous Subcutaneous Insulin Infusion (CSII)
- Self administration
T1DM Associated conditions
Cystic fibrosis
Wolfram Syndrome
Bardet-Biedl Syndrome
Associated Auto-immune
- Thyroid disease
- Coeliac disease
- Pernicious anaemia
- Addison’s Disease
- IgA deficiency
Glucose Monitoring Targets (Children)
On waking and before meals : 4-7 mol/L
After meals: 5-9 mmol/l
Glucose Monitoring Targets (Adults)
On waking: 5-7 mmol/L
Before meals: 4-7 mol/L
90 mins after meals: 5-9mmol/L